A settlement agreement has been reached between Fresenius Medical Care and the plaintiffs involved in the current multidistrict litigation suit, but both parties have asked for the case to be stayed while a settlement deal is reached.
Currently, the deal is that Fresenius will pay $250 million to the plaintiffs and that 97% of the plaintiffs must agree to the deal by July 2016. Most of the money will come from insurers. The reason for the stay is to see if the plaintiffs in the current bellwether cases will come to join the settlement or whether they will continue to pursue trial.
The reason for the settlement isn’t just because the dialysis fluid could cause dangerous levels of bicarbonate to build up in the body and cause cardiac arrest. It was also because Fresenius hid knowledge of the trouble from other dialysis centers that it didn’t know. The FDA initiated a Class I recall when knowledge of the problem reached them. However, they did not ask for a reformulation of the product. It needs to be administered with care because the amount of fluid necessary changes depending on the acidity of the blood during the time of dialysis. But the fluids in question were marketed as one-size-fits-all solutions.
If you believe that your loved one suffered cardiac trouble due to Granuflo, you have to act fast to be a part of this settlement. Over 4,000 people are part of the suit and the plaintiffs have until July, 2016 to decide whether to agree to it or not. Don’t let your opportunity for compensation slip away. Contact John Foy & Associates.